Psychedelic-assisted therapies: The past, and the need to move forward responsibly
International Journal of Drug Policy May 25, 2019 John Gardner, Adrian Carter, Kerry O’Brien et al. 23 citations
Recent clinical studies illustrate that psychedelics such as LSD and psilocybin may represent much-needed new treatment options for mood disorders and alcohol and other drug use disorders. More clinical studies are required to confirm the safety and efficacy of psychedelic-assisted therapies, but the cultural stigma that has surrounded psychedelics since the 1960s has hindered research. This...